Mereo Biopharma Group Plc Adr stock is traded at $0.2757, with a volume of 205,252. It is down -1.68% in the last 24 hours and down -21.25% over the past month. Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Previous Close:
$0.2804
Open:
$0.271
24h Volume:
205,252
Relative Volume:
0.40
Market Cap:
$44.03M
Revenue:
$506.20K
Net Income/Loss:
-$42.05M
P/E Ratio:
-
EPS:
-$0.2647
Net Cash Flow:
-$31.36M
1W Performance:
-4.77%
1M Performance:
-21.25%
6M Performance:
+16.23%
1Y Performance:
-84.34%
1-Day Range:
$0.2707$0.2894
1-Week Range:
$0.2707$0.313
52-Week Range:
$0.2$2.37
Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile
Name
Mereo Biopharma Group Plc AdrSector
HealthcareIndustry
BiotechnologyPhone
4403330237300Address
ONE CAVENDISH PLACE, LONDON, United KingdomMarket Cap
Revenue
Net Income
Cash Flow
EPS